Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease
July 5th 2024Expert panelists discuss the implementation of a treat-to-target approach for the long-term management of inflammatory bowel disease (IBD), drawing upon data from the STARDUST and REACT-2 trials to support their recommendations and insights into optimizing patient outcomes through this strategy.
Read More
Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease
July 5th 2024Expert gastroenterologists delve into the concept of transmural healing as a treatment target for both ulcerative colitis and Crohn's disease, sharing insights on their preferred timeframes for reassessing treatment progress, monitoring methods, and the effectiveness of intestinal ultrasounds in the management of these conditions.
Read More
Recommended Targets When Treating Ulcerative Colitis/Crohn’s Disease in Clinic
June 10th 2024Silvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, discuss their preferred recommended targets for managing ulcerative colitis (UC) or Crohn's disease (CD), emphasizing the aggressive approach required to achieve these targets effectively.
Read More
Treat-to-target in Inflammatory Bowel Disease
June 10th 2024Medical experts in inflammatory bowel disease (IBD) define the concept of "treat-to-target" within the context of IBD and provide current recommendations on treatment targets for ulcerative colitis and Crohn's disease, the two main forms of IBD.
Read More